Cargando…

Dose constraints for whole breast radiation therapy based on the quality assessment of treatment plans in the randomised Danish breast cancer group (DBCG) HYPO trial

PURPOSE: Quality assessment of the treatment plans in the Danish Breast Cancer Group (DBCG) HYPO trial was carried out based on prospectively reported dosimetric parameters and evidence-based dose constraints for whole breast radiation therapy were derived. MATERIALS AND METHODS: From 2009 to 2014,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomsen, M.S., Berg, M., Zimmermann, S., Lutz, C.M., Makocki, S., Jensen, I., Hjelstuen, M.H.B., Pensold, S., Hasler, M.P., Jensen, M.-B., Offersen, B.V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079332/ https://www.ncbi.nlm.nih.gov/pubmed/33937532 http://dx.doi.org/10.1016/j.ctro.2021.03.009

Ejemplares similares

Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG)
por: Cold, S, et al.
Publicado: (2005)

Selection criteria for early breast cancer patients in the DBCG proton trial – The randomised phase III trial strategy
por: Stick, Line Bjerregaard, et al.
Publicado: (2021)

Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study
por: Buhl, Anna Sofie Kappel, et al.
Publicado: (2018)

Neoadjuvant chemotherapy and HER2 dual blockade including biosimilar trastuzumab (SB3) for HER2-positive early breast cancer: Population based real world data from the Danish Breast Cancer Group (DBCG)
por: Berg, Tobias, et al.
Publicado: (2020)

Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials
por: Kyndi, Marianne, et al.
Publicado: (2008)

Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial
por: Skriver, Signe Korsgaard, et al.
Publicado: (2020)

First-Line Treatment of HER2-Positive Metastatic Breast Cancer With Dual Blockade Including Biosimilar Trastuzumab (SB3): Population-Based Real-World Data From the DBCG
por: Celik, Alan, et al.
Publicado: (2022)

Gene Expression Signatures That Predict Outcome of Tamoxifen-Treated Estrogen Receptor-Positive, High-Risk, Primary Breast Cancer Patients: A DBCG Study
por: Lyng, Maria B., et al.
Publicado: (2013)

Danish Breast Cancer Cooperative Group
por: Christiansen, Peer, et al.
Publicado: (2016)

Global MicroRNA Expression Profiling of High-Risk ER+ Breast Cancers from Patients Receiving Adjuvant Tamoxifen Mono-Therapy: A DBCG Study
por: Lyng, Maria B., et al.
Publicado: (2012)

Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical Trial
por: Shenasa, Elahe, et al.
Publicado: (2022)

How traumatic is breast cancer? Post-traumatic stress symptoms (PTSS) and risk factors for severe PTSS at 3 and 15 months after surgery in a nationwide cohort of Danish women treated for primary breast cancer
por: O'Connor, M, et al.
Publicado: (2011)

Incidence of hypothyroidism after treatment for breast cancer—a Danish matched cohort study
por: Falstie-Jensen, Anne Mette, et al.
Publicado: (2020)

Intraoperative irradiation in breast cancer: preliminary results in 80 patients as partial breast irradiation or anticipated boost prior to hypo-fractionated whole breast irradiation
por: Li, X., et al.
Publicado: (2021)

Rates of re‐excision and conversion to mastectomy after breast‐conserving surgery with or without oncoplastic surgery: a nationwide population‐based study
por: Heeg, E., et al.
Publicado: (2020)

Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study
por: Falstie-Jensen, Anne Mette, et al.
Publicado: (2019)

Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98
por: Alkner, S., et al.
Publicado: (2017)

Modeling of Hypo/Hyperglycemia and Their Impact on Breast Cancer Progression Related Molecules
por: Adham, Sirin A. I., et al.
Publicado: (2014)

Danish population health measured by the EQ-5D-5L
por: Jensen, Morten B., et al.
Publicado: (2021)

Comparative Study of Hypo-Fractionated Radiotherapy Versus Conventional Radiotherapy in Breast Cancer
por: Narwariya, Abhinav, et al.
Publicado: (2022)

Cost of illness of HER2-positive and metastatic and recurrent HER2-positive breast cancer – a Danish register-based study from 2005 to 2016
por: Spanggaard, M., et al.
Publicado: (2022)

Hypo and Hyperthyroidism
por: Hixson, J. S.
Publicado: (1915)

Increasing incidence of trunk melanoma in young Danish women.
por: Osterlind, A., et al.
Publicado: (1987)

Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
por: Koukourakis, Ioannis M., et al.
Publicado: (2021)

Male breast cancer: clinicopathological characterization of a National Danish cohort 1980–2009
por: Jylling, Anne Marie Bak, et al.
Publicado: (2020)

Clinical Outcomes of Patients with Metastatic Breast Cancer Treated with Hypo-Fractionated Liver Radiotherapy
por: Mushonga, Melinda, et al.
Publicado: (2023)

The long-term financial consequences of breast cancer: a Danish registry-based cohort study
por: Jensen, Laura Schärfe, et al.
Publicado: (2017)

Radiation pneumonitis and pulmonary function with lung dose–volume constraints in breast cancer irradiation
por: Blom Goldman, U., et al.
Publicado: (2013)

Cases of Hypo-Thyroidism
por: Milne, C.
Publicado: (1914)

Hypo-Substitute for Opiates
Publicado: (1899)

Fellows’ Hypo Phosphites
Publicado: (1880)

Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study
por: Cold, Søren, et al.
Publicado: (2022)

Radiation-Induced Toxicity Risks in Photon Versus Proton Therapy for Synchronous Bilateral Breast Cancer
por: Stick, Line Bjerregaard, et al.
Publicado: (2021)

Mothering a population: How Danish mothers experience newborn dried blood spot samples and their considerations about re-use of samples for research purposes
por: Nordfalk, Francisca, et al.
Publicado: (2022)

Comorbidity and survival of Danish breast cancer patients from 1995 to 2005
por: Cronin-Fenton, D P, et al.
Publicado: (2007)

Preliminary toxicity results using partial breast 3D-CRT with once daily hypo-fractionation and deep inspiratory breath hold
por: Kowalchuk, Roman O., et al.
Publicado: (2018)

The role of H1 antihistamines in contralateral breast cancer: a Danish nationwide cohort study
por: Bens, Annet, et al.
Publicado: (2020)

End-to-end framework for automated collection of large multicentre radiotherapy datasets demonstrated in a Danish Breast Cancer Group cohort
por: Refsgaard, Lasse, et al.
Publicado: (2023)

Use of prescription drugs and risk of postoperative red blood cell transfusion in breast cancer patients: a Danish population-based cohort study
por: Thomsen, Anne Marie L., et al.
Publicado: (2017)

Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977–2001
por: Taylor, Carolyn W., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ntv6alsq7tqho3n75n1581vkts